Next-Generation Imaging

Latest News

Study finds geographic disparities in MRI use in prostate cancer
Study finds geographic disparities in MRI use in prostate cancer

March 27th 2025

The use of pre-diagnostic MRI was 3.8% in 2012, which increased to 32.6% in 2019.

FDA approves PET imaging product Gozellix for prostate cancer
FDA approves PET imaging product Gozellix for prostate cancer

March 20th 2025

64Cu-SAR-bisPSMA shows efficacy in detection of biochemically recurrent prostate cancer
64Cu-SAR-bisPSMA shows efficacy in detection of biochemically recurrent prostate cancer

March 6th 2025

FDA updates in urology: February 2025
FDA updates in urology: February 2025

March 3rd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.